Concepedia

Elena Élez

EÉ

22

Publications

2.1K

Citations

18

H-Index

2017

Active since

Affiliations

Sorbonne Université(Current)

National Cancer Center Hospital East

Hôpital Saint-Antoine

Memorial Sloan Kettering Cancer Center

Vall d'Hebron Hospital Universitari

Elena Élez is an author at Sorbonne Université specializing in medicine, pathology, and oncology.

Top concepts

Publications per year

2017–2025

22

Publications

22

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

Luis A. Díaz, Kai‐Keen Shiu, Tae‐Won Kim et al. · The Lancet Oncology · 2022 · 818 citations · Full text

, , +9

Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study.

Thierry André, Kai‐Keen Shiu, Tae Won Kim et al. · Journal of Clinical Oncology · 2020 · 196 citations

, , +16

Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer

Thierry André, Elena Élez, Eric Van Cutsem et al. · New England Journal of Medicine · 2024 · 158 citations

Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC.

Luis A. Díaz, Aurélien Marabelle, Jean‐Pierre Delord et al. · Journal of Clinical Oncology · 2017 · 124 citations

, , +13

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

Thierry André, Elena Élez, Heinz‐Josef Lenz et al. · The Lancet · 2025 · 115 citations

, , +6

Rows per page

1–5 of 22